⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
GSK News
GSK plc American Depositary Shares (Each representing two Ordinary Shares)
Juvenescence successfully completes Phase 1 clinical trial of PAI-1 inhibitor and strengthens clinical development leadership
globenewswire.com
GSK
JNJ
AZN
ViiV Healthcare reports positive 12-month data showing investigational bNAb lotivibart (N6LS) maintains high levels of viral suppression in long-acting HIV treatment regimen
businesswire.com
PFE
GSK
ViiV Healthcare presents pipeline data for two investigational HIV treatment therapies with potential for twice-yearly dosing
businesswire.com
PFE
GSK
Frontier Biotech und GSK schließen globale Exklusivlizenzvereinbarung für therapeutische Anwendungen mit kleinen interferierenden RNAs USA - Deutsch USA - English USA - español USA - English USA - Français
prnewswire.com
GSK
35Pharma to be Acquired by GSK to Accelerate Development of HS235, a Potential Best-in-Class Investigational Medicine for Pulmonary Hypertension (PH)
globenewswire.com
GSK
Frontier Biotech et GSK concluent un accord de licence exclusif à l'échelle mondiale pour les thérapies fondées sur les petits ARN interférents (siRNA) USA - Français USA - English USA - español USA - English USA - Deutsch
prnewswire.com
GSK
Drug-Resistant Epilepsy Market to Accelerate With Significant CAGR by 2036 as Demand for Advanced Therapies Increases | DelveInsight
prnewswire.com
LIVN
PTC
UCB
XENE
AQST
TAK
BHVN
KNOP
VRTX
SUPN
GSK
SNY
MD
ERS Genomics launches new Early Access Express License
prnewswire.com
GSK
MRK
TMO
CTVA
DHR
CRL
Frontier Biotech and GSK Enter Global Exclusive Licensing Agreement for Small Interfering RNA Therapeutics USA - English USA - English
prnewswire.com
GSK
Frontier Biotech and GSK Enter Global Exclusive Licensing Agreement for Small Interfering RNA Therapeutics
prnewswire.com
GSK